(Q36943310)

17 August 2017

1 reference

title

Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations (English)

1 reference

17 August 2017

1 reference

3

Jonas Bergh

1 reference

17 August 2017

2

Maria Albertsson

1 reference

17 August 2017

Jane Ahlqvist-Rastad

1

1 reference

17 August 2017

Gunnar Birgegård

4

1 reference

17 August 2017

Peter Johansson

5

1 reference

17 August 2017

Bertil Jonsson

6

1 reference

17 August 2017

Elisabeth Kjellen

7

1 reference

17 August 2017

Sven Påhlman

8

1 reference

17 August 2017

Björn Zackrisson

9

1 reference

17 August 2017

Anders Osterborg

10

1 reference

17 August 2017

publication date

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

24

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

267-272

1 reference

Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12032-007-0037-5

Breast cancer trial with erythropoietin terminated unexpectedly

21 January 2018

1 reference

12 December 2020

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study

1 reference

12 December 2020

Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies

1 reference

12 December 2020

Impact of epoetin-beta on survival of patients with lymphoproliferative malignancies: long-term follow up of a large randomized study

1 reference

12 December 2020

Darbepoetin alfa for the treatment of chemotherapy-induced anemia: disease progression and survival analysis from four randomized, double-blind, placebo-controlled trials.

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

1 reference

12 December 2020

Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: A meta-analysis

1 reference

12 December 2020

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Do erythropoietin receptors on cancer cells explain unexpected clinical findings?

1 reference

12 December 2020

Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity.

1 reference

12 December 2020

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

1 reference

12 December 2020

Erythropoietin administration during primary treatment for locally advanced cervical carcinoma is associated with poor response to radiation

1 reference

12 December 2020

[Anemia in head and neck cancers].

1 reference

12 December 2020

Anti-Epo receptor antibodies do not predict Epo receptor expression

1 reference

12 December 2020

10.1007/S12032-007-0037-5

Identifiers

DOI

1 reference

17 August 2017

1 reference